Match Document Document Title Score
7387791 Liposome drug delivery  
This invention comprises pharmaceutical compositions for administering a biologically active compound to an animal. Particularly provided are proliposomal compositions that are advantageously used...
62
6418384 Acoustic emission monitor, method and memory media for solid material processing machinery  
Apparatus and method for monitoring acoustic emission signals in machinery that processes solid material such as aspirin to detect rubbing conditions. The apparatus includes an acoustic signal...
61
6303172 Method of treating commercial grade products to remove undesirable odors and flavors  
A method of treating antimicrobial products, dairy products, pharmaceutical products and other products having offensive tastes or odors to remove the off-odors and off-tastes from the products....
61
US20140311944 The Good Samaritan A Digital Lifesaving Kit  
The Good Samaritan a self-contained storage device attachable to existing cell phone or factory built into specific cell phone that assists in providing basic emergency aid. Device contains...
61
US20160272729 METHOD OF TREATING A PATHOLOGICAL SYNDROME AND A PHARMACEUTICAL AGENT  
A method of treating a pathological syndrome includes administration of an activated form of ultra-low doses of antibodies to an antigen, wherein said activated form is obtained by repeated...
60
5047258 Aqueous spray-coating process  
A process for spray-coating tablets and the like utilizing only an acrylate enteric polymer and plasticizer in water is disclosed. The process can be practiced on a commercial scale and requires...
60
6106775 Modifying an atmosphere with an aqueous composition including sodium bicarbonate and acetylsalicylic acid  
Evaporation devices and associated methods for introducing humidity into an atmosphere. The evaporation device includes a substantially rigid shell encasing an absorbent material and having a...
60
8865187 Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity  
A novel pharmaceutical composition is provided by which nonsteroidal anti-inflammatory drugs (NSAIDs) are added directly to phospholipid-containing oil such as lecithin oils or to a bio-compatible...
60
8486922 Composition  
This disclosure relates to a pharmaceutical composition that includes a first agent selected from the group consisting of an oxidative phosphorylation inhibitor, an ionophore, and an adenosine...
60
7811610 Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity  
The invention provides hops (Humulus lupulus) extracts or derivatives thereof for use in treating a patient prophylactically and/or therapeutically for ulcerogenic-type disorders of the stomach...
60
8287904 Stable soft capsule dosage form for acetylsalicylic acid  
A stable soft gel dosage form for acetylsalicylic acid (ASA), aspirin, is provided wherein soft gel capsules containing the ASA can be stored for prolonged periods under typical home storage...
60
US20120045507 STABLE SOFT CAPSULE DOSAGE FORM FOR ACETYLSALICYLIC ACID  
A stable soft gel dosage form for acetylsalicylic acid (ASA), aspirin, is provided wherein soft gel capsules containing the ASA can be stored for prolonged periods under typical home storage...
60
6482831 Covalently coupled benzoylecgonine, egconine and ecgonidine derivatives  
The present invention relates to a novel class of covalently coupled benzoylecgonine, ecgonine and ecgonidine derivatives that are useful for alleviating the symptoms of immunoregulatory...
60
US20140179630 USE OF DOCASATRIENES, RESOLVINS, AND THEIR STABLE ANALOGS IN THE TREATMENT OF AIRWAY DISEASES AND ASTHMA  
The present invention is generally drawn to novel isolated therapeutic agents, termed resolvins, generated from the interaction between a dietary omega-3 polyunsaturated fatty acid (PUFA) such as...
60
US20050261255 Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma  
The present invention is generally drawn to novel isolated therapeutic agents, termed resolvins, generated from the interaction between a dietary omega-3 polyunsaturated fatty acid (PUFA) such as...
60
US20080096961 Use of Docosatrienes, Resolvins and Their Stable Analogs in the Treatment of Airway Diseases and Asthma  
The present invention is generally drawn to novel isolated therapeutic agents, termed resolving, generated from the interaction between a dietary omega-3 polyunsaturated fatty acid (PUFA) such as...
60
US20120264713 USE OF DOCOSATRIENES, RESOLVINS, AND THEIR STABLE ANALOGS IN THE TREATMENT OF AIRWAY DISEASES AND ASTHMA  
The present invention is generally drawn to novel isolated therapeutic agents, termed resolvins, generated from the interaction between a dietary omega-3 polyunsaturated fatty acid (PUFA) such as...
60
US20060293288 Use of resolvins to treat gastrointestinal diseases  
The present invention is generally drawn to novel isolated therapeutic agents, termed resolvins, generated from the interaction between a dietary omega-3 polyunsaturated fatty acid (PUFA) such as...
60
US20100016432 RESOLVINS: BIOTEMPLATES FOR NOVEL THERAPEUTIC INTERVENTIONS  
The present invention is generally drawn to novel isolated therapeutic agents, termed resolving, generated from the interaction between a dietary omega-3 polyunsaturated fatty acid (PUFA) such as...
60
US20040116408 Resolvins: biotemplates for novel therapeutic interventions  
The present invention is generally drawn to novel isolated therapeutic agents, termed resolving, generated from the interaction between a dietary omega-3 polyunsaturated fatty acid (PUFA) such as...
60
US20130217771 RESOLVINS: BIOEMPLATES FOR NOVEL THERAPEUTIC INTERVENTIONS  
The present invention is generally drawn to novel isolated therapeutic agents, termed resolvins, generated from the interaction between a dietary omega-3 polyunsaturated fatty acid (PUFA) such as...
60
5641511 Granular drug delivery system  
A novel granular drug delivery system having a gel-forming dietary fiber that can be made into a an orally-ingestible dispersion by admixture with a liquid that can deliver an effective dose of a...
59
9975684 Interactive dispensing bottle cap  
A bottle cap is adapted to retain a quantity of an additive, such as, e.g., aspirin, vitamins, nutritional supplements or the like. The additive is retained in an isolated condition within a...
59
8236857 Extended-release formulation for reducing the frequency of urination and method of use thereof  
Methods and compositions for reducing the frequency of urination are disclosed. One method comprises administering to a subject in need thereof an effective amount of a pharmaceutical composition...
59
US20120164193 EXTENDED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF  
Methods and compositions for reducing the frequency of urination are disclosed. One method comprises administering to a subject in need thereof an effective amount of a pharmaceutical composition...
59
5736536 Method for treating vascular leak syndrome  
A novel method for preventing, stabilizing or causing regression of vascular leak syndrome is disclosed. The method comprises administering to a patient in need thereof a compound selected from...
59
US20140154220 Methods and Compositions for Improved Tissue Regeneration by Suppression of Interferon-Gamma and Tumor Necrosis Factor-Alpha  
The present invention discloses methods, compositions and devices for improving tissue regeneration by suppressing the effects of several proinflammatory cytokines such as TNF-α and IFN-γ....
59
US20050192346 Process for making nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclooxygenase-2 inhibitors  
The invention encompasses a novel process for making compounds of Formula I which are prodrugs of cyclooxygenase-2 selective inhibitors that convert in vivo to diaryl-2-(5H)-furanones and also...
59
10335454 Combination and use  
The present invention relates to the use of one or more compounds selected from the following: caffeic acid, thymol, aspirin, benzydamine hydrochloride, diclofenac sodium, flurbiprofen, ibuprofen,...
59
US20110301239 USE OF NOVEL LIPID MEDIATORS TO INHIBIT ANGIOGENESIS  
The present invention is generally drawn to novel isolated therapeutic agents, termed resolvins, generated from the interaction between a dietary omega-3 polyunsaturated fatty acid (PUFA) such as...
59
4983401 Sustained release pharmaceutical preparations having pH controlled membrane coatings  
A sustained-release pharmaceutical preparation utilizing a pH controlled diffusion membrane composed of a pH sensitive film-forming polymer. The film forming polymer may be an enteric polymer...
59
4405643 Treatment of acute pulmonary edema with arginine esters  
Pharmaceutical compositions for use in the relief of acute pulmonary edema, different types of shock including anaphylactic shock, shock induced by bacterial endotoxins, and hyperfibrinolysis...
58
US20030195242 Use of Cox-2 inhibitors to prevent recurrences of herpesvirus infections  
Selective inhibitors for COX-2 were discovered to prevent the reactivation of viruses that cause latent infections such as herpes simplex virus (HSV-1 and HSV-2). Using mice with a latent...
58
US20130330300 High Telomerase Activity Bone Marrow Mesenchymal Stem Cells, Methods of Producing the Same and Pharmaceuticals and Treatment Methods Based Thereon  
Disclosed are isolated human bone marrow mesenchymal stem cells having high telomerase activity (tBMMSCs). Also disclosed are isolated human CD34+ bone marrow mesenchymal stem cells. Also...
58
4888455 Water leak detector and method therefor  
In the absence of moisture, a separation between a pair of electrical contacts is maintained by a material that becomes frangible when moistened. When the material becomes moist, it breaks and the...
58
5635477 Cyclic compounds useful as inhibitors of platelet glycoprotein IIB/IIIA  
This invention relates to novel cyclic compounds containing carbocyclic ring systems useful as antagonists of the platelet glycoprotein IIb/IIIa complex, to pharmaceutical compositions containing...
58
US20140288028 NOVEL PHARMACEUTICAL SALTS AND POLYMORPHS OF A FACTOR XA INHIBITOR  
The present invention provides for salts comprising a compound of Formula I and an acid that has activity against mammalian factor Xa. The present invention is also directed to methods of making...
58
US20120164192 DELAYED RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF  
Methods and compositions for reducing the frequency of urination are disclosed. One method comprises administering to a subject in need thereof an effective amount of a pharmaceutical composition...
58
US20120264721 ANALOGUES OF CILOSTAZOL  
This invention relates to novel compounds which are derivatives of the phosphodiesterase inhibitor, cilostazol and pharmaceutically acceptable salts thereof. This invention also provides...
58
8686117 Platelet aggregation inducing substance  
A platelet aggregation inducing substance containing as an active ingredient a polypeptide having a peptide fragment represented by formula (1) (component A): -(Pro-X-Gly)n- (1) wherein X...
58
US20110300216 Chewable, swallowable and effervescent solid dosage form for oral delivery of pharmaceutical actives  
A tablet comprising: (a) an active ingredient; and (b) at least one member of an effervescent couple, wherein said tablet dissolves in water in not more than three minutes and in the mouth in not...
58
US20040043165 Lidding components for containers  
A container is sealed using a lidding material and induction sealing techniques. The container possesses a main body portion (e.g., a bottle or jar) housing contents of the container (e.g.,...
57
US20120141554 DELAYED RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF  
Methods and compositions for reducing the frequency of urination are disclosed. One method comprises administering to a subject in need thereof an effective amount of a pharmaceutical composition...
57
5028632 Taste masked medicated pharmaceutical  
The addition of an extremely small quantity of an anesthetizing agent such as phenol to a medicament dosed saccharide floss serves to numb the taste buds sufficiently that undesirable taste...
57
5593971 Method for preventing onset of hypertension employing a cholesterol lowering drug  
A method is provided for preventing or reducing the risk of hypertension in normotensive patients having insulin resistance by administering a cholesterol lowering drug, such as pravastatin, alone...
57
US20020022058 Unit dose of material in system and method  
The invention provides a unit dose of an orally consumable material, having a predetermined pharmaceutically effective amount of at least one nonprescription discomfort reliever and a...
57
4093103 Tablet container  
Containers for storing various pills are provided which have excellent water vapor permeation resistance and which includes child-resistant opening features. The container includes a top and a...
57
8445015 Extended-release formulation for reducing the frequency of urination and method of use thereof  
Methods and compositions for reducing the frequency of urination are disclosed. One method comprises administering to a subject in need thereof an effective amount of a pharmaceutical composition...
56
US20120244221 EXTENDED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF  
Methods and compositions for reducing the frequency of urination are disclosed. One method comprises administering to a subject in need thereof an effective amount of a pharmaceutical composition...
56
US20120294943 EXTENDED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF  
Methods and compositions for reducing the frequency of urination are disclosed. One method comprises administering to a subject in need thereof an effective amount of a pharmaceutical composition...
56


Search
« search again